SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 29th, 2021 • Boston Therapeutics, Inc. • Pharmaceutical preparations • New York
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of June 25, 2021, is by and among Boston Therapeutics, Inc., a Delaware corporation with offices located at 5900 Hollis Street, Suite P, Emeryville, CA 94608 (the “Company”), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • June 29th, 2021 • Boston Therapeutics, Inc. • Pharmaceutical preparations • New York
This REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of June 25, 2021, is by and among Boston Therapeutics, Inc., a Delaware corporation with offices located at 5900 Hollis Street, Suite P, Emeryville, CA 94608 (the “Company”), and the undersigned buyers (each, a “Buyer,” and collectively, the “Buyers”).
SECURITY AND PLEDGE AGREEMENTSecurity and Pledge Agreement • June 29th, 2021 • Boston Therapeutics, Inc. • Pharmaceutical preparations • New York
SECURITY AND PLEDGE AGREEMENT, dated as of June 25, 2021 (this “Agreement”), made by Boston Therapeutics, Inc., a Delaware corporation with offices located at 354 Merrimack Street #4, Lawrence, MA 01843 (the “Company”), and each of the undersigned direct and indirect Domestic Subsidiaries of the Company from time to time, if any (each a “Grantor” and together with the Company, collectively, the “Grantors”), in favor of HT Investments MA LLC, in its capacity as collateral agent (in such capacity, the “Collateral Agent” as hereinafter further defined) for the Noteholders (as defined below) party to the Securities Purchase Agreement (as defined below).
GUARANTYGuaranty • June 29th, 2021 • Boston Therapeutics, Inc. • Pharmaceutical preparations • New York
This GUARANTY, dated as of June 25, 2021 (this “Guaranty”), is made by each of the undersigned (each a “Guarantor”, and collectively, the “Guarantors”), in favor of HT Investments MA LLC, a Delaware limited liability company, in its capacity as collateral agent (in such capacity, the “Collateral Agent” as hereinafter further defined) for the “Buyers” party to the Securities Purchase Agreement (each as defined below).
EXCHANGE AGREEMENTExchange Agreement • June 29th, 2021 • Boston Therapeutics, Inc. • Pharmaceutical preparations • New York
THIS EXCHANGE AGREEMENT (the “Agreement”) is made as of the ___ day of June 2021, by and between, Boston Therapeutics, Inc., a Delaware corporation (the “Company”), and ______________ (the “Holder”).
